Ron Howard Discusses New Documentary on Photographer Richard Avedon at Cannes
Oscar-winning director Ron Howard returns to the Cannes Film Festival with a documentary about legendary photographer Richard Avedon. The film explores Avedon's career and the changing face of America.
France 24Oscar-winning filmmaker Ron Howard has returned to the Cannes Film Festival with a new documentary titled "Avedon" about legendary photographer Richard Avedon. The project marks Howard's latest exploration of storytelling after directing films such as "Apollo 13" and "A Beautiful Mind".
Background on the Documentary Howard reflected on a lifetime of storytelling and the creative curiosity that has driven him for nearly seven decades in Hollywood. The documentary examines Avedon's work and its connection to broader cultural shifts in the United States.
Howard spoke about the current state of Hollywood and his ongoing work in the industry. He discussed how the festival continues to serve as an important platform for filmmakers and audiences.
“From 'Apollo 13' to 'A Beautiful Mind', Howard reflects on a lifetime of storytelling, the changing face of America and the creative curiosity that still drives him after nearly seven decades in Hollywood.”
The appearance at Cannes highlights Howard's continued presence in both documentary and narrative filmmaking.
Key Facts
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…